Omthera Pharmaceuticals, Inc.
37 articles about Omthera Pharmaceuticals, Inc.
-
Omthera Pharmaceuticals, Inc. Stockholders Approve Acquisition by AstraZeneca PLC
7/16/2013
-
Omthera Pharmaceuticals, Inc. Announces Waiver of Lock-Up Restriction
7/11/2013
-
Omthera Pharmaceuticals, Inc. Announces NDA Submission for Epanova™ for the Treatment of Patients With Very High Triglycerides
7/9/2013
-
Omthera Pharmaceuticals, Inc. Announces Termination of Antitrust Waiting Period
6/27/2013
-
Omthera Pharmaceuticals, Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders
6/13/2013
-
Omthera Pharmaceuticals, Inc. Announces First Quarter 2013 Financial Results
5/28/2013
-
AstraZeneca PLC Boosts Heart Drug Biz With $443 Million Omthera Pharmaceuticals, Inc. Buy
5/28/2013
-
Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
4/17/2013
-
Omthera Pharmaceuticals, Inc. Prices Upsized IPO Below the Range at $8
4/11/2013
-
Omthera Pharmaceuticals, Inc. Files for a $75 Million IPO
3/11/2013
-
Omthera Pharmaceuticals, Inc. Presents Data From Analysis of EVOLVE Trial Showing That Epanova Lowers ApoC-III, a Key Predictor of Cardiovascular Risk
11/9/2012
-
Omthera Pharmaceuticals, Inc. Blasts Competitor Out of the Way as Omega-3 Makes Headlights in Phase 3 Study
11/6/2012
-
Omthera Pharmaceuticals, Inc. Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
11/2/2012
-
Omthera Pharmaceuticals, Inc. Announces Positive Top-Line Results from Phase 3 EVOLVE Study
4/26/2012
-
Omthera Pharmaceuticals, Inc. to Present at Leerink Swann and Company 2012 Global Healthcare Conference and Citi 2012 Global Healthcare Conference
2/15/2012
-
Omthera Pharmaceuticals, Inc. Announces Positive Long Term Bioavailability Data Comparing Epanova(TM) to Lovaza(R)
1/9/2012
-
Omthera Pharmaceuticals, Inc. to Present at the 30th Annual J.P. Morgan Healthcare Conference
1/5/2012
-
Omthera Pharmaceuticals, Inc. Completes Enrollment of Pivotal Phase III EVOLVE Trial for Epanova(TM) in Patients With Very High Triglycerides
11/29/2011
-
Omthera Pharmaceuticals, Inc.. to Present at the 23rd Annual Piper Jaffray Health Care Conference
11/21/2011
-
Timothy J. Maines Joins Omthera Pharmaceuticals, Inc. as Vice President of Quality
10/25/2011